MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$299,222K
EPS
-$4.66
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
215,256
General and administrative
100,217
Total operating expenses
315,473
Loss from operations
-315,473
Interest income
24,479
Interest expense
7,531
Other (expense) income, net
-1,089
Total other income, net
15,859
Loss before provision for income taxes
-299,614
Provision for income taxes
1
Net loss
-299,615
Change in fair value on marketable securities
393
Comprehensive loss
-299,222
Basic EPS
-4.66
Diluted EPS
-4.66
Basic Average Shares
64,233,814
Diluted Average Shares
64,233,814
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$299,222K Change in fair value onmarketable securities$393K Net loss-$299,615K Interest income$24,479K Loss beforeprovision for income taxes-$299,614K Provision for income taxes$1K Total other income,net$15,859K Interest expense$7,531K Other (expense)income, net-$1,089K Loss from operations-$315,473K Total operatingexpenses$315,473K Research and development$215,256K General andadministrative$100,217K

Vera Therapeutics, Inc. (VERA)

Vera Therapeutics, Inc. (VERA)